Key facts
- Biodock’s last known valuation is $15.0M (Mar 2021).
- It has raised $6.0M; the latest was Seed Round ($3.8M) in Nov 2025.
- Notable investors include Y Combinator, Andreessen Horowitz, Soma Capital, Operator Partners, TQ Ventures — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Biodock
- ·The full record, as it builds
Funding rounds
No funding rounds for Biodock are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Biodock
Developer of a cloud-based analysis platform designed to analyze and store biological data, including microscopy images. The company's platform makes research painless by managing storage, running jobs in the cloud across powerful graphics processing units (GPU), and providing access through a user interface designed specifically for scientists, enabling clinicians to upload, analyze, and download quantification on a single-cell level and graphs in publication-ready formats.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2020
- Employees
- 5
- Website
- biodock.ai/
- Ownership
- Privately Held (backing)
Biodock doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Biodock shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Biodock in its N-PORT filings yet. We sweep new filings monthly.